NICE u-turn backs Sanofi’s Gaucher disease drug
admin 1st June 2017 Uncategorised 0It is now looking likely that Sanofi’s Cerdelga will be funded on the NHS in England and Wales to treat type 1 Gaucher disease, after a u-turn by cost regulators.
More: NICE u-turn backs Sanofi’s Gaucher disease drug
Source: News